Patents by Inventor Kamal Mehta

Kamal Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190356502
    Abstract: Methods and systems for remote configuration of a building control system into a BMS based system are disclosed herein. One remote management device allowing a remote user to connect a new or legacy system to a BMS network includes a processor and memory, the memory having executable instructions that execute to receive identification information that allow a user on a user device to access a remote management application, send instructions to the gateway device to initiate a discovery protocol at the gateway device to identify any network devices connected to the gateway device, receive data related to each identified network device from the gateway device and create a device profile for each identified network device, initiate a discovery of origination points protocol to discover all origination points for data that are relevant to a particular device of the identified network devices, and update the device profile for that particular device.
    Type: Application
    Filed: May 17, 2018
    Publication date: November 21, 2019
    Inventors: Ajay N. Nair, Prabhat Ranjan, Sheeladitya Karmakar, Suresh Vemuri, Kamal Mehta, Yogiraj Dattaram More
  • Publication number: 20140072628
    Abstract: Disclosed herein is a stable pharmaceutical composition comprising a substrate having deposited on its surface a layer comprising saxagliptin or pharmaceutically acceptable salts thereof, wherein a seal coat is not present between the substrate and the saxagliptin layer.
    Type: Application
    Filed: September 11, 2013
    Publication date: March 13, 2014
    Applicant: Glenmark Generics Ltd.
    Inventors: Atul Kaushik, Arra Ganga Srinivas, Kamal Mehta
  • Patent number: 8563535
    Abstract: An aqueous gel composition of the present invention comprising about 0.1 to 0.3 wt % adapalene and about 2.5 to 5.0 wt % benzoyl peroxide, as active ingredients, wherein both the active ingredients are stabilized in hydrophilic gelling matrix of pH dependent gelling agent comprising crosslinked, acrylic acid-based polymer(s).
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: October 22, 2013
    Inventors: Kamal Mehta, Lalatendu Panigrahi, Uday Kumar Nayak, Balakrishna Patro
  • Publication number: 20120252897
    Abstract: An aqueous gel composition of the present invention comprising about 0.1 to 0.3 wt % adapalene and about 2.5 to 5.0 wt % benzoyl peroxide, as active ingredients, wherein both the active ingredients are stabilized in hydrophilic gelling matrix of pH dependent gelling agent comprising crosslinked, acrylic acid-based polymer(s).
    Type: Application
    Filed: March 23, 2012
    Publication date: October 4, 2012
    Applicant: Glenmark Generics Limited
    Inventors: Kamal Mehta, Lalatendu Panigrahi, Uday Kumar Nayak, Balakrishna Patro
  • Publication number: 20110207779
    Abstract: The present invention relates to a process for the preparation of esomeprazole magnesium containing R-isomer greater than about 0.1% by wt. In particular, the present invention relates to a process for the preparation of esomeprazole magnesium dihydrate containing R-isomer greater than about 0.1% by wt.
    Type: Application
    Filed: April 28, 2010
    Publication date: August 25, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Koilpillai Joseph Prabahar, Veerabhadra Swamy Hiremath, Milind Moreshwar Gharpure, Nagan Nirmalan Kandaswamy, Avekumar Digambar Dabe, Kamal Mehta, Pankajkumar Shinde
  • Publication number: 20110052687
    Abstract: The present invention provides an extended release tablet of paliperidone, comprising a) a core containing paliperidone and at least one water soluble and/or gellable polymer, b) a coating comprising at least one water insoluble or permeable polymer, and a water soluble and/or gellable polymer and optionally an enteric polymer.
    Type: Application
    Filed: August 25, 2010
    Publication date: March 3, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Pankaj Shinde, Hidaytulla Aga, Rajadeep Gupta
  • Publication number: 20110053898
    Abstract: A topical pharmaceutical composition comprising therapeutically effective amounts of vitamin D or vitamin D analogues, corticosteroid and a straight chain C6-C28 fatty alcohol.
    Type: Application
    Filed: August 24, 2010
    Publication date: March 3, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Amol Mandhare, Shantesh Patil, Tapan Nayak, Lalatendu Panigrahi
  • Publication number: 20110038928
    Abstract: The present invention is directed to a novel rapidly dissolvable pharmaceutical composition comprising zolmitriptan or pharmaceutically acceptable salts or esters thereof and least one direct compression filler. The pharmaceutical compositions of the present invention can advantageously be prepared in a solid dosage form, e.g. a tablet, utilizing directly compressible ingredients.
    Type: Application
    Filed: August 10, 2010
    Publication date: February 17, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Srinivas Ganga Arra, Chandramala A. Kaushal, Manish Maheshwari
  • Publication number: 20100028425
    Abstract: The present invention relates to immediate release pharmaceutical compositions for oral administration comprising micronized atovaquone particles and at least one drug, wherein about 90% of the atovaquone particles have a volume diameter between about 4 ?m to about 8 ?m; and having a uniform release profile after a storage for at least three months at 40° C. and 75% relative humidity.
    Type: Application
    Filed: July 22, 2009
    Publication date: February 4, 2010
    Applicant: GLENMARK GENERICS LTD.
    Inventors: Kamal Mehta, Sanjay Pandurang Lade, Srinivas G. Arra
  • Publication number: 20100008988
    Abstract: The present invention provides pharmaceutical compositions, essentially comprising less than about 95% by weight of an aliphatic amine polymer. The present invention relates to pharmaceutical compositions comprising aliphatic amine polymers of sevelamer hydrochloride, sevelamer carbonate and colesevelam hydrochloride; and methods of preparing pharmaceutical compositions thereof.
    Type: Application
    Filed: July 13, 2009
    Publication date: January 14, 2010
    Applicant: GLENMARK GENERICS, LTD.
    Inventors: KAMAL MEHTA, SRINIVAS GANGA ARRA, HIDAYTULLA AGA
  • Publication number: 20100008986
    Abstract: The present invention relates to the pharmaceutical composition comprising sumatriptan succinate and naproxen sodium, with a proviso that both the active components are in admixture with each other.
    Type: Application
    Filed: July 13, 2009
    Publication date: January 14, 2010
    Applicant: GLENMARK GENERICS, LTD.
    Inventors: KAMAL MEHTA, HIDAYTULLA AGA, SANJAY KUMAR SAHU
  • Publication number: 20100003319
    Abstract: The present invention relates generally to formulations containing raloxifene or pharmaceutical salts thereof, as the active pharmaceutical ingredient and a process for preparing the same.
    Type: Application
    Filed: June 30, 2009
    Publication date: January 7, 2010
    Applicant: GLENMARK GENERICS LTD.
    Inventors: Pavak Mehta, Kamal Mehta, Abhijeet Upadhye
  • Publication number: 20090233898
    Abstract: The present invention generally relates to a stable pharmaceutical composition that does not have a film coating which contains simvastatin, ezetimibe or pharmaceutically-acceptable salts thereof, and ascorbic acid.
    Type: Application
    Filed: March 10, 2009
    Publication date: September 17, 2009
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Abhay Mahajan, Pankaj Sinde
  • Publication number: 20070275052
    Abstract: Pharmaceutical compositions containing ezetimibe or its pharmaceutically acceptable salt that is substantially free of microcrystalline cellulose or crystalline cellulose are disclosed. Also disclosed are pharmaceutical compositions containing micronized particles of ezetimibe.
    Type: Application
    Filed: May 24, 2007
    Publication date: November 29, 2007
    Applicant: Glenmark Pharmaceuticals Limited
    Inventors: Abhay Mahajan, Kamal Mehta
  • Publication number: 20070185194
    Abstract: The present invention relates to stable oral compositions of azithromycin monohydrate with reduced bitterness, processes for making these compositions, and methods of using these compositions for the treatment of microbial infections. The stable oral compositions of azithromycin include an azithromycin premix, at least one pharmaceutically accepted excipient, and, optionally, at least one taste-masking agent. The azithromycin premix includes azithromycin monohydrate and at least one additive.
    Type: Application
    Filed: July 1, 2004
    Publication date: August 9, 2007
    Inventors: Kamal Mehta, Rajeev Mathur, Sujata Paul, Sanjeev Sethi, Rajiv Malik
  • Publication number: 20050202081
    Abstract: The invention provides stable pharmaceutical compositions comprising ACE inhibitor(s) and other pharmaceutically active substances which are susceptible to degradation, as well as processes for the preparation thereof, and methods of treatment involving administration of such compositions.
    Type: Application
    Filed: January 14, 2003
    Publication date: September 15, 2005
    Inventors: Deepak Bahl, Ravi Kochhar, Puneet Sharma, Vishnubhotla Nagaprasad, Rajeev Mathur, Kamal Mehta